Badrul Chowd­hury jumps ship at the FDA and moves to As­traZeneca, join­ing an ex­o­dus of agency of­fi­cials

Twen­ty-year FDA vet­er­an Badrul Chowd­hury, most re­cent­ly di­rec­tor of the Cen­ter for Drug Eval­u­a­tion and Re­search’s (CDER) Di­vi­sion of Pul­monary, Al­ler­gy and Rheuma­tol­ogy Prod­ucts, has tak­en a job this month as se­nior vice pres­i­dent at As­traZeneca.

As­traZeneca tells End­points News that Chowd­hury will be mov­ing in­to a top re­search job, tak­ing on the role of se­nior vice pres­i­dent of re­search de­vel­op­ment at As­traZeneca and Med­Im­mune, where he will be head­ing up the Res­pi­ra­to­ry, In­flam­ma­tion, and Au­toim­mu­ni­ty, In­no­v­a­tive Med­i­cine and Ear­ly De­vel­op­ment Bio­med Unit.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER